{"id":"W4400808178","doi":"10.21203/rs.3.rs-4557891/v1","title":"Phase Ⅱ Study of Combined Sintilimab and Anlotinib with Gemcitabine plus Cisplatin in Advanced Biliary Tract Cancer: Efficacy, Safety and Optimize Dose","year":2024,"lang":"en","type":"preprint","venue":"Research Square","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Science and Technology Program of Zhejiang Province; National Natural Science Foundation of China; Innovent Biologics","keywords":"Gemcitabine; Biliary tract cancer; Cisplatin; Medicine; Oncology; Maximum tolerated dose; Biliary tract; Phase (matter); Internal medicine; Cancer; Chemotherapy; Chemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001728741,0.00155095,0.002134209,0.000510079,0.0003711244,0.001214939,0.000883971,0.00127036,0.004988221],"category_scores_gemma":[0.0009045131,0.0008202419,0.002018091,0.0005034668,0.0009476632,0.001029643,0.0004544872,0.003396268,0.001095694],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001168298,"about_ca_system_score_gemma":0.002203468,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001416546,"about_ca_topic_score_gemma":0.002801086,"domain_scores_codex":[0.9994593,0.000263233,0.00002471941,0.00009064424,0.00005006261,0.000112057],"domain_scores_gemma":[0.9992869,0.0001149573,0.0001640033,0.00008396721,0.00005036195,0.000299729],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8771293,0.0434708,0.001920703,0.0005216748,0.001823556,0.00007764473,0.0001031068,0.002532086,0.0146499,0.0002748016,0.002570874,0.05492562],"study_design_scores_gemma":[0.5292258,0.4540193,0.00505814,0.00003770238,0.001158464,0.0001244842,0.00006181531,0.001197425,0.004714278,0.0002581343,0.004106971,0.00003760414],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.992215,0.001735189,0.0006718065,0.0005324841,0.0002053685,0.001694048,0.001017618,0.00008488093,0.001843646],"genre_scores_gemma":[0.9815949,0.002380254,0.002601673,0.0007350844,0.0001929294,0.002914715,0.002402592,0.0000546593,0.007123185],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004988221,"threshold_uncertainty_score":0.01668727,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05688693833924165,"score_gpt":0.4148484397295592,"score_spread":0.3579615013903176,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}